CoChat

Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin

Jain, Varun, Mohebtash, Mahsa, Rodrigo, Maria E., Ruiz, George, Atkins, Michael B., Barac, Ana · 2018 · Journal of Immunotherapy

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

The immune checkpoint inhibitors have brought about a paradigm shift in the treatment of many cancers and are being used as the first line therapy in increasing number of aggressive malignancies, including metastatic melanoma. Their adverse effects, mostly mediated by an uncontrolled overactivation of the immune system, may compromise the therapeutic benefit. Combination immune checkpoint therapies in particular, have higher therapeutic efficacy, but have also been associated with a higher incidence of severe immune-related adverse effects including autoimmune lymphocytic myocarditis. Recent clinical reports of this rare and life threatening condition indicated rapid progression of severe hemodynamic and electrical instability, with or without acute decompensated heart failure, reduced ejection fraction and shock, pointing to the need for early recognition, diagnosis and prompt management. Current guidelines for management of other immune-related adverse effects recommend high-dose glucocorticoids, with consideration of immunomodulators, such as infliximab in patients with severe colitis. However, knowledge about the treatment approaches in immune-related myocarditis remains extremely scarce. Here we report a case of severe, steroid refractory, lymphocytic myocarditis that occurred after the first cycle of combination immunotherapy with the programmed cell death protein-1 inhibitor, nivolumab, and the cytotoxic T-lymphocyte-associated protein 4 blocker, ipilimumab, for metastatic melanoma. We discuss treatment approaches including the role for transvenous pacemaker, advanced heart failure support, and interdisciplinary decision making.

Overview

Integrity signals

Registry

Crossref · 10.1097/cji.0000000000000239

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 12 references

Cited by

See all 97

Metadata

Authors
Jain, V., Mohebtash, M., Rodrigo, M. E., Ruiz, G., Atkins, M. B., & Barac, A.
Affiliations
  • Georgetown University (US)
  • MedStar Union Memorial Hospital (US)
Corresponding author
  • Jain, Varun
  • Rodrigo, Maria E.
  • Barac, Ana
Venue
Journal of Immunotherapy
Published
2018-09
Volume
41
Issue
7
Pages
332-335
ISSN
1524-9557 (ISSN-L)
OpenAlex
W2810244089
Cited by
96
References
12
Citations by year
2026: 8 · 2025: 5 · 2024: 9 · 2023: 8 · 2022: 16 · 2021: 15 · 2020: 19 · 2019: 12 · 2018: 3
FWCI
4.61
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Immunotherapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
Keywords
autoimmune myocarditis, immune checkpoint inhibitors, antithymocyte globulin, nivolumab, ipilimumab, immune-related adverse events, metastatic melanoma, combination immunotherapy, heart failure, transvenous pacemaker, immunomodulatory therapy
MeSH terms
Ipilimumab, Nivolumab, Aged, Antilymphocyte Serum, Autoimmune Diseases, Drug Resistance, Drug Therapy, Combination, Glucocorticoids, Humans, Immunotherapy, Male, Melanoma, Myocarditis, Neoplasm Metastasis, Skin Neoplasms, Treatment Outcome, Programmed Cell Death 1 Receptor, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin. https://app.cochat.ai/papers/10.1097/cji.0000000000000239
The paper
Jain, V., Mohebtash, M., Rodrigo, M. E., Ruiz, G., Atkins, M. B., & Barac, A. (2018). Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin. Journal of Immunotherapy. https://doi.org/10.1097/cji.0000000000000239

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.